Knowledge of PAI-1 and tPA regulation in hepatocytes in obesity may suggest therapeutic strategies for improving fibrinolysis and lowering the risk of thrombosis in this setting. Here, SERPINE1 is linked to obesity due to melanocortin 4 receptor deficiency.